Company will launch its latest innovation at national conference on pain management LAS VEGAS , Sept. 4, 2018 /PRNewswire/ -- Tomorrow at PAINWeek 2018, NeuroMetrix Inc. (Nasdaq: NURO) , will unveil its latest breakthrough for the treatment of chronic pain.
WALTHAM, Mass. , Aug. 29, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today reported that it will be both exhibiting and sponsoring a diabetic neuropathy symposium at the 28th Annual Meeting of NEURODIAB held in Rome, Italy September 4-7 .
WALTHAM, Mass. , Aug. 28, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), today reported that it will present three scientific posters at the upcoming PAINWeek 2018 National Pain Conference to be held in Las Vegas, NV, September 4-8. The PAINWeek 2018 Abstract Book may be accessed here
Presentation Shifted to 10:00 am on September 6, 2018 WALTHAM, Mass. , Aug. 27, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix , Inc. (Nasdaq:NURO) reported that the time previously announced for its presentation at the H.C.Wainwright 20th Annual Global Investment Conference has been shifted to 10:00 am
WALTHAM, Mass. , Aug. 23, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix , Inc. (Nasdaq:NURO) today announced it will be a presenting company at the 20th Annual Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is being held September 4 - 6, 2018, at The St. Regis New York in New York City. Shai N. Gozani, M.D., Ph.D.,
WALTHAM, Mass. , Aug. 21, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), today reported that it had achieved the second development milestone under its strategic collaboration with GSK Consumer Healthcare . A milestone payment of $3.8 Million was made by GSK.
Initial $3.8M Milestone Achieved under GSK Strategic Collaboration WALTHAM, Mass. , July 19, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), today reported financial and business highlights for the quarter ended June 30, 2018 . The Company develops and markets novel therapies, based on
WALTHAM, Mass. , July 12, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix , Inc.(NASDAQ:NURO) announced today that it plans to issue its 2018 second quarter financial results before the opening of the market on Thursday, July 19, 2018. The Company will host a conference call at 8:00 a.m., Eastern
WALTHAM, Mass. , July 05, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,004,445. The patent covers novel technology that enhances DPNCheck ® device performance by detecting and rejecting erroneous
“Moving Beyond Opioids: How Technological Innovations Can Impact Chronic Pain” earns top award in healthcare publicity campaign category WALTHAM, Mass. , June 28, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) in conjunction with its public relations firm, InkHouse, received two
